ABC | Volume 114, Nº5, May 2020

Statement Brazilian Cardiology Society Statement for Management of Pregnancy and Family Planning in Women with Heart Disease – 2020 Arq Bras Cardiol. 2020; 114(5):849-942 225. Elkayam U, Jalnapurkar S, Barakkat MN, Khatri N, Kealey AJ, Mehra A, et al. Pregnancy-Associated Acute Myocardial Infarction: A Review of Contemporary Experience in 150 Cases Between 2006 and 2011. Circulation. 2014;129(16):1695-702. 226. Hayes SH, KimESH, Saw J, AdlamD, Arslanian-EngorenC, Economy KE, et al. Spontaneous Coronary Artery Dissection: Current State of the Science: A Scientific Statement from the American Heart Association. Circulation. 2018;137(19):e523-57. 227. Garcia M, Mulvagh SL, Merz CN, Buring JE, Manson JE. Cardiovascular disease in women: clinical perspectives. Circ Res. 2016;118(8):1273-93. 228. Desoye G, Schweditsch MO, Pfeiffer KP, Zechner R, Kostner GM. Correlation of hormones with lipid and lipoprotein levels during normal pregnancy and postpartum. J Clin Endocrinol Metab. 1987;64(4):704-12. 229. Faludi AA, IzarMCO, Saraiva JFK, Chacra APM, BiancoHT, Afiune ANeto, et al. Atualização da Diretriz Brasileira de Dislipidemias e Prevenção da Aterosclerose – 2017. Arq Bras Cardiol. 2017;109(2 Suppl 1):1-76. 230. Basar R, Uzum AK, Canbaz B, Dogansen SC, Kalayoglu-Besisik S, Altay- Dadin S, et al. Therapeutic apheresis for sever hypertriglyceridemia in pregnancy. Arch Gynecol Obstet. 2013;287(5):839-43. 231. Russi G. Severe dyslipidemia in pregnancy: The role of therapeutic apheresis. Transfus Apher Sci. 2015;53(3):283-7. 232. Wild R, Weedin EA, Wilson D. Dyslipidemia in pregnancy. Cardiol Clinic. 2015;33(2):209-15. 233. De Souza AW, de Carvalho JF. Diagnostic and classification criteria of Takayasu arteritis. J Autoimmun. 2014 Feb-Mar;48-49:79-83. 234. Kim ESH, Beckman J. Takayasu arteritis: challenges in diagnosis and management. Heart. 2018;104(7):558-65. 235. Machen L, Clowse ME. Vasculitis and Pregnancy. Rheum Dis Clin North Am. 2017;43(2):239-47. 236. Gatto M, Iaccarino L, Canova M, Zen M, Nalotto L, Ramonda R, et al. Pregnancy and vasculitis: A systematic reviewof the literature. Autoimmun Rev. 2012;11(6-7):A447-59. 237. Seyahi E. Takayasu arteritis: an update. Curr Opin Rheumatol. 2017;29(1):51-6. 238. Assad AP, da Silva TF, Bonfa E, Pereira RM. Maternal and Neonatal Outcomes in 89 Patients with Takayasu Arteritis (TA): Comparison Before and After the TA Diagnosis. J Rheumatol. 2015;42(10):1861-4. 239. McCrindle BW, Rowley AH, Newburger JW, Burns JC, Bolger AF, Gewitz M, et al. Diagnosis, Treatment, and Long-TermManagement of Kawasaki Disease:AScientificStatement forHealthProfessionalsFromtheAmerican Heart Association. Circulation. 2017;135(17):e927-99. 240. JCS Joint Working Group. Guidelines for diagnosis and management of cardiovascular sequelae in Kawasaki disease (JCS 2013). Digest version. Circ J. 2014;78(10):2521-62. 241. Ávila WS, Freire AF, Soares AA, Pereira AN, Nicolau JC. Pregnancy in Womanwith Kawasaki Disease andMultiple Coronary Artery Aneurysms. Arq Bras Cardiol. 2018; 110(1):97-100. 242. Gordon CT, Jimenez-Fernandez S, Daniels LB, Kahn AM, Tarsa M, Matsubara T, et al. Pregnancy in Women with a History of Kawasaki Disease: Management and Outcomes. BJOG. 2014;121(11):1431-8. 243. Thomas E, Yang J, Xu J, Lima FV, Stergiopoulos K. Pulmonary Hypertension and Pregnancy Outcomes: Insights From the National Inpatient Sample. J AmHeart Assoc. 2017;6(10). pii: e006144. 244. SunXuefeng,JunFeng,JuhongShi.Pregnancyandpulmonaryhypertension. An explory analysis of risk factors and outcomes. Medicine 2018; 97:44 51 245. Sliwa K, van Hagen IM, Budts W, Swan L, Sinagra G, Caruana M, et al. Pulmonary hypertension and pregnancy outcomes. Data from the Registry of Pregnancy and Cardiac Disease (ROPAC) of the European Society of Cardiology. Eur J Heart Fail. 2016;18(9):119-28. 246. Svetlichnaya J, Janmohammed M, De Marco T. Special Situations in PulmonaryHypertension Pregnancy and Right Ventricular Failure. Cardiol Clin. 2016;34(3):473-87. 247. Gatzoulis MA, Adatia I, Celermajer D, Denton C, Ghofrani A, et al. Updated Clinical Classification of Pulmonary Hypertension. J Am Coll Cardiol. 2013;62(25):D34-41. 248. Weiss BM, Zemp L, Seifert B, Hess OM. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol. 1998;31(7):1650-7. 249. Kiely DG, Cockrill BA, Safdar Z, Wilson VJ, Al Hazmi M, et al. Statement on pregnancy in pulmonary hypertension from the Pulmonary Vascular Research Institute. Pulm Circ. 2015;5(3):435-65. 250. Jaïs X, Olsson KM, Barbera JA, Blanco I, Torbicki A, Peacock A, et al. Pregnancy outcomes in pulmonary arterial hypertension in the modern management era. Eur Respir J. 2012;40(4):881-5. 251. Olson KM, Channick R. Pregnancy in pulmonary arterial hypertension. Eur Respir Rev. 2016;25(142):431-7. 252. Thomas S, Safdar Z, Torres F, Pacheco LD, Feldman J, et al. Management of Pulmonary Arterial Hypertension During Pregnancy. Chest. 2013;143(5):1330-6. 253. Wanga S, Silversides C, Dore A, de Waard V, Mulder B. Pregnancy and Thoracic Aortic Disease: Managing the Risks. Can J Cardiol. 2016;32(1):78-85. 254. Donnelly RT, Pinto NM, Kocolas I, Yetman AT. The immediate and long- term impact of pregnancy on aortic growth rate and mortality in women with Marfan syndrome. J Am Coll Cardiol. 2012;60(3):224-9. 255. Smith K, Gros B. Pregnancy-related acute aortic dissection in Marfan syndrome:Areviewoftheliterature.CongenitHeartDis. 2017;12(3):251-60. 256. Brasil.Ministério da Saúde. Portaria N.223, de 10 de maio de 2010. Síndrome de Turner. Protocolo Clínico e Diretrizes Terapêuticas. Brasilia;2010. 257. GolandS,ElkayamU.PregnancyandMarfansyndrome.AnnCardiothorac Surg. 2017;6(6):642-53. 258. Frise CJ, Pitcher A, Mackillop L. Loeys–Dietz syndrome and pregnancy: The first ten years. Int J Cardiol. 2017 Jan;226:21-5. 259. Dias JC, Ramos Jr NA, Gontijo ED, Luquetti A, Shikanai-YasudaMA, Coura JR, et al. II Consenso Brasileiro em Doença de Chagas. Epidemiol Serv Saúde. 2016;25(Esp):7-86. 260. Martins-Melo FR, Lima MS, Ramos Júnior AN, Alencar CH, Heukelbach J. Prevalence of Chagas disease in pregnant women and congenital transmission of Trypanosoma cruzi in Brazil: a systematic review and meta-analysis. Trop Med Int Health. 2014;19(8):943-57. 261. Carlier Y, Sosa-Estani S, Luquetti AO, Buekens P. Congenital Chagas disease: an update. Mem Inst Oswaldo Cruz. 2015;110(3):363-8. 262. Norman FF, Lopez-Velez R. Mother-to-child transmission of Trypanosoma cruzi infection (Chagas disease): a neglected problem. Trans R Soc Trop Med Hyg. 2014;108(7):388-90. 263. Brasil. Ministério da Saúde. Guia de vigilância em saúde. 2ª ed. Brasilia;2017. 264. AnanthCV,KeyesKM,WapnerRJ.Pre-eclampsiarates intheUnitedStates, 1980-2010: age-period-cohort analysis. BMJ. 2013 Nov;347:f6564. 265. Wagnew M, Dessalegn M, Worku A, Nyagero J. Trends of preeclampsia/ eclampsia andmaternal and neonatal outcomes amongwomen delivering in addis ababa selected government hospitals, Ethiopia: a retrospective cross-sectional study. Pan Afr Med J. 2016;25(Suppl 2):12. 266. Malachias MV, Gomes MA, Nobre F, Alessi A, Feitosa AD, Coelho EB. 7th Brazilian Guideline of Arterial Hypertension: Chapter 2. Diagnosis and Classification. Arq Bras Cardiol. 2016;107(3 Suppl 3):7-13. 936